These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 29327118)

  • 1. Effect of CPAP therapy on liver disease in patients with OSA: a review.
    Liu X; Miao Y; Wu F; Du T; Zhang Q
    Sleep Breath; 2018 Dec; 22(4):963-972. PubMed ID: 29327118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonalcoholic fatty liver disease and obstructive sleep apnea.
    Aron-Wisnewsky J; Clement K; Pépin JL
    Metabolism; 2016 Aug; 65(8):1124-35. PubMed ID: 27324067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obstructive Sleep Apnea and the Liver.
    Parikh MP; Gupta NM; McCullough AJ
    Clin Liver Dis; 2019 May; 23(2):363-382. PubMed ID: 30947882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous Positive Airway Pressure Does Not Improve Nonalcoholic Fatty Liver Disease in Patients with Obstructive Sleep Apnea. A Randomized Clinical Trial.
    Ng SSS; Wong VWS; Wong GLH; Chu WCW; Chan TO; To KW; Ko FWS; Chan KP; Hui DS
    Am J Respir Crit Care Med; 2021 Feb; 203(4):493-501. PubMed ID: 32926803
    [No Abstract]   [Full Text] [Related]  

  • 5. Association between continuous positive airway pressure and serum aminotransferases in patients with obstructive sleep apnea.
    Chen LD; Zhang LJ; Lin XJ; Qi JC; Li H; Wu Z; Xu QZ; Huang YP; Lin L
    Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):587-594. PubMed ID: 29224042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating Obstructive Sleep Apnea and Chronic Intermittent Hypoxia Improves the Severity of Nonalcoholic Fatty Liver Disease in Children.
    Sundaram SS; Halbower AC; Klawitter J; Pan Z; Robbins K; Capocelli KE; Sokol RJ
    J Pediatr; 2018 Jul; 198():67-75.e1. PubMed ID: 29752170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous Positive Airway Pressure Therapy on Nonalcoholic Fatty Liver Disease in Patients With Obstructive Sleep Apnea.
    Kim D; Ahmed A; Kushida C
    J Clin Sleep Med; 2018 Aug; 14(8):1315-1322. PubMed ID: 30092894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of effective versus sham continuous positive airway pressure on liver injury in obstructive sleep apnoea: Data from randomized trials.
    Jullian-Desayes I; Tamisier R; Zarski JP; Aron-Wisnewsky J; Launois-Rollinat SH; Trocme C; Levy P; Joyeux-Faure M; Pepin JL
    Respirology; 2016 Feb; 21(2):378-85. PubMed ID: 26567858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of obstructive sleep apnea treatment by continuous positive airway pressure on cardiometabolic biomarkers: a systematic review from sham CPAP randomized controlled trials.
    Jullian-Desayes I; Joyeux-Faure M; Tamisier R; Launois S; Borel AL; Levy P; Pepin JL
    Sleep Med Rev; 2015 Jun; 21():23-38. PubMed ID: 25220580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between non-alcoholic fatty liver disease and obstructive sleep apnea.
    Umbro I; Fabiani V; Fabiani M; Angelico F; Del Ben M
    World J Gastroenterol; 2020 May; 26(20):2669-2681. PubMed ID: 32523319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of continuous positive airway pressure on liver enzymes in obstructive sleep apnea: A meta-analysis.
    Chen LD; Lin L; Zhang LJ; Zeng HX; Wu QY; Hu MF; Xie JJ; Liu JN
    Clin Respir J; 2018 Feb; 12(2):373-381. PubMed ID: 27614004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fixed and autoadjusting continuous positive airway pressure treatments are not similar in reducing cardiovascular risk factors in patients with obstructive sleep apnea.
    Patruno V; Aiolfi S; Costantino G; Murgia R; Selmi C; Malliani A; Montano N
    Chest; 2007 May; 131(5):1393-9. PubMed ID: 17494789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous Positive Airway Pressure in Patients With Obstructive Sleep Apnea and Non-Alcoholic Steatohepatitis: A Systematic Review and Meta-Analysis.
    Labarca G; Cruz R; Jorquera J
    J Clin Sleep Med; 2018 Jan; 14(1):133-139. PubMed ID: 29151428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysyl Oxidase as a Serum Biomarker of Liver Fibrosis in Patients with Severe Obesity and Obstructive Sleep Apnea.
    Mesarwi OA; Shin MK; Drager LF; Bevans-Fonti S; Jun JC; Putcha N; Torbenson MS; Pedrosa RP; Lorenzi-Filho G; Steele KE; Schweitzer MA; Magnuson TH; Lidor AO; Schwartz AR; Polotsky VY
    Sleep; 2015 Oct; 38(10):1583-91. PubMed ID: 26085300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of continuous positive airway pressure treatment on glucose metabolism in patients with obstructive sleep apnea.
    Martínez-Ceron E; Fernández-Navarro I; Garcia-Rio F
    Sleep Med Rev; 2016 Feb; 25():121-30. PubMed ID: 26146025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obstructive Sleep Apnea, Hypoxia, and Nonalcoholic Fatty Liver Disease.
    Mesarwi OA; Loomba R; Malhotra A
    Am J Respir Crit Care Med; 2019 Apr; 199(7):830-841. PubMed ID: 30422676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of continuous positive airway pressure therapy for nonalcoholic fatty liver disease in patients with obstructive sleep apnea.
    Hirono H; Watanabe K; Hasegawa K; Kohno M; Terai S; Ohkoshi S
    World J Clin Cases; 2021 Jul; 9(19):5112-5125. PubMed ID: 34307562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between obstructive sleep apnea and nonalcoholic fatty liver disease in nonobese adults.
    Qi JC; Huang JC; Lin QC; Zhao JM; Lin X; Chen LD; Huang JF; Chen X
    Sleep Breath; 2016 May; 20(2):529-35. PubMed ID: 26174847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is obstructive sleep apnea a risk factor for diabetes?
    Clarenbach CF; West SD; Kohler M
    Discov Med; 2011 Jul; 12(62):17-24. PubMed ID: 21794205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sleep apnea, metabolic disease, and the cutting edge of therapy.
    Light M; McCowen K; Malhotra A; Mesarwi OA
    Metabolism; 2018 Jul; 84():94-98. PubMed ID: 28966076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.